Abzena signs manufacturing and bioconjugation deal with Telix

This article was originally published here

UK-based life sciences group Abzena has signed GMP manufacturing and bioconjugation agreements with Australia-based Telix Pharmaceuticals.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply